apoInvestor
| DAX | TecDAX | Dow Jones |
|---|---|---|
|
|
||
| Aktuell: 16.533,11 Diff.%: +0,78% Kurszeit: 05.12. 17:55 | ||
Top/Flop
| DAX | Kurs | Zeit | Diff.% | |
|---|---|---|---|---|
 |
DAIMLER TRUCK HLDG NA ON | 31,340 | 17:42 | +3,43% |
|
SIEMENS ENERGY AG NA O.N. | 11,635 | 17:35 | +2,96% |
|
FRESENIUS SE+CO.KGAA O.N. | 28,720 | 17:35 | -1,95% |
|
SARTORIUS AG VZO O.N. | 282,800 | 17:35 | -1,81% |
| TecDAX | Kurs | Zeit | Diff.% | |
|
MORPHOSYS AG O.N. | 27,550 | 17:35 | +11,27% |
|
AIXTRON SE NA O.N. | 34,120 | 17:35 | +4,02% |
|
NEMETSCHEK SE O.N. | 76,660 | 17:35 | -2,17% |
|
SARTORIUS AG VZO O.N. | 282,800 | 17:35 | -1,81% |
| Dow Jones | Kurs | Zeit | Diff.% | |
|
Apple | 193,500 | 23:30 | +2,15% |
|
Merck & Co | 106,230 | 22:16 | +1,11% |
|
Procter & Gamble Company | 146,760 | 23:07 | -3,49% |
|
Goldman Sachs Group | 341,750 | 23:06 | -2,19% |
- Marktüberblick
-
| Name | Kurs | Zeit | Diff.% | ||
|---|---|---|---|---|---|
|
 |
DAX | 16.533,11 | 17:55 | +0,78% |
|
|
HDAX | 8.889,38 | 17:55 | +0,75% |
|
|
MDAX | 26.491,45 | 17:55 | +0,46% |
|
|
TECDAX | 3.199,16 | 17:55 | +0,41% |
|
|
Euro Stoxx 50 | 4.452,77 | 17:50 | +0,86% |
|
|
DOW JONES IND. | 36.124,56 | 23:03 | -0,22% |
|
|
NASDAQ COMPOSITE IND | 14.229,91 | 23:16 | +0,31% |
|
S&P 500 | 4.567,18 | 22:20 | -0,06% | |
|
NIKKEI 225 INDEX | 32.775,82 | 07:20 | -1,37% | |
|
UMLAUFR. ALLER OEFFE | 2,32% | 13:42 | -2,52% | |
|
EURO-BUND-FUTURE | 134,41 | 02:48 | -0,09% | |
|
EUR/USD SPOT | 1,0792 | 03:07 | -0,05% |
Marktberichte
| Zeit | Schlagzeilen |
|---|---|
| 05.12. / 23:11 | BUSINESS WIRE: Foodmate erwirbt Barth Industria |
| 05.12. / 22:47 | WDH/INDEX-MONITOR: Schott Pharma wird in SDax |
| 05.12. / 22:20 | INDEX-MONITOR: Schott Pharma wird in SDax aufg |
| 05.12. / 22:20 | ROUNDUP/Aktien New York Schluss: Rally des Dow g |
| 05.12. / 22:14 | Aktien New York Schluss: Rally des Dow gerät ins S |
| 05.12. / 21:55 | BUSINESS WIRE: Der Bericht von VoxelMatters fü |
| 05.12. / 21:43 | BUSINESS WIRE: Lattice setzt die rasche Erweite |
| 05.12. / 21:34 | EQS-Adhoc: Merck KGaA: Evobrutinib erreicht primä |
| ...mehr | |
